[WIP] Product Vision
Your Health Buddy - India's first longevity-focused, family-first personal health record platform
Vision Statement
Become India's default personal longevity OS for 100M+ Indians by democratizing longevity science through health data transformation.
Product Philosophy
"GitHub for your health data — own your history, optimize your longevity"
Strategic Positioning
Primary Market Position
Category: Personal Health Records (PHR) with longevity optimization
Target Market: Health-conscious Indian families seeking data-driven longevity insights
Geographic Focus: India-first with ABDM-native integration
Unique Value Proposition
India's first family-first personal health OS that combines:
Longevity-First Approach: Track biological age using 9 standard blood biomarkers (PhenoAge)
Family-Centric Design: Multi-generational health management vs individual-only competitors
India-Specific Moats: Multi-language OCR, ABDM integration, pollution-adjusted metrics
Competitive Differentiation
Against 40+ Analyzed Competitors
Longevity-First Moat:
All competitors focus on disease management or basic tracking
AarogyaDost uniquely positions on biological age optimization
PhenoAge calculator with C-index > 0.70 for mortality prediction
Family-First Moat:
100% of analyzed competitors are individual-focused
AarogyaDost enables family health management and sharing
Multi-generational health insights and comparisons
ABDM-Native Moat:
First PHR platform built specifically for ABDM ecosystem
Native integration with 760M+ ABHA IDs
Seamless interoperability with Indian healthcare providers
India-Specific Technical Moats:
Multi-language OCR (Hindi, Tamil, Telugu, English)
Indian lab format recognition (Thyrocare, Dr. Lal PathLabs, Apollo, SRL)
Pollution-adjusted health metrics for Indian cities
Regional health reference ranges for Indian population
Key Strategic Pillars
1. Data Ownership & Control
Users maintain complete ownership and control of their health data
Privacy-first architecture with local-first data storage
No vendor lock-in, full data portability
2. Scientific Foundation
All recommendations backed by peer-reviewed longevity research
PhenoAge biological age calculation using validated biomarkers
Evidence-based health optimization suggestions
3. Accessibility & Inclusion
Making longevity science accessible beyond wealthy demographics
Multi-language support for broader Indian population
Affordable pricing (₹499 individual, ₹999 family)
4. Family-Centric Design
Multi-generational health management
Family health sharing and collaboration features
Comparative health insights across family members
5. India-First Approach
Built specifically for Indian healthcare ecosystem
ABDM-native integration from day one
Cultural and linguistic adaptation for Indian users
Market Opportunity
Total Addressable Market (TAM)
India's digital health market: $5.6B (2025) → projected rapid growth
760M+ ABHA ID holders (potential user base)
Growing health consciousness in Indian middle class
Target Customer Segments
Primary: Health-conscious Indian families (25-55 age group)
Household income: ₹8L+ annually
Urban and semi-urban populations
Early adopters of health technology
Secondary: Chronic disease patients and elderly
Diabetes, hypertension, heart disease patients
Elderly population seeking health monitoring
Families managing multiple health conditions
Revenue Strategy
Pricing Model
Individual Premium (Longevity Tier)
100,000 users
₹499
₹59.88 Cr ($7.2M)
Family Plan (up to 5 members)
50,000 families
₹999
₹59.94 Cr ($7.2M)
Total Annual Revenue
₹119.82 Cr ($14.4M)
Monetization Strategy
Freemium model with basic PHR features
Premium subscriptions for longevity insights and family features
Future: B2B partnerships with healthcare providers and insurers
Strategic Execution Priorities
Phase 1: MVP & Market Validation (Q1 2026)
Launch Demo UI with biological age tracking
Implement family profile management
Validate product-market fit with early adopters
Phase 2: Market Entry (Q2-Q3 2026)
Full product launch with OCR and data extraction
Customer acquisition and growth
Partnership development with labs and providers
Phase 3: Scale & Expansion (Q4 2026+)
Geographic expansion across Indian states
Advanced longevity features and AI insights
B2B partnerships and enterprise offerings
Success Metrics
User Metrics
Monthly Active Users (MAU): Target 100K by end of 2026
Family Plan Adoption: 50% of premium users
User Retention: 80% monthly retention rate
Business Metrics
Annual Recurring Revenue (ARR): ₹120 Cr target
Customer Acquisition Cost (CAC): < ₹2,000
Lifetime Value (LTV): > ₹10,000
Product Metrics
Biological age calculation accuracy: >90%
OCR extraction accuracy: >95% for Indian lab reports
Family health data sharing adoption: >60%
Updated: January 3, 2026 Incorporates insights from comprehensive competitor analysis and strategic positioning research
Last updated